Employees: 11-50
Investment Stage: Series A
Portfolio 5
Date | Name | Website | Total Raised | Location |
03.06.2020 | Prilenia T... | prilenia.c... | $105.5M | Israel, Te... |
17.11.2015 | Amylyx | amylyx.com | $171.9M | - |
- | Emulate, I... | emulatebio... | $175.75M | United Sta... |
- | Verge Geno... | vergegenom... | $68M | United Sta... |
- | Orphazyme ... | orphazyme.... | $41.84M | Denmark, C... |
Mentions in press and media 7
Date | Title | Description | Source |
12.03.2024 | Prilenia Plans to Submit Marketing Authorization Application... | NAARDEN, Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)-- Prilenia Therapeutics B.V., a clinical ... | forbion.co... |
07.01.2022 | Amylyx Pharma’s IPO lands $190M as ALS drug begins FDA revie... | Amylyx Pharmaceuticals has joined the public markets with a $190 million IPO that will support the c... | medcitynew... |
20.07.2021 | Amylyx Pharmaceuticals Closes $135M Series C Financing Led b... | Amylyx Pharmaceuticals, Inc. today announced the closing of an oversubscribed $135 million Series C ... | marketscre... |
03.06.2020 | Prilenia Therapeutics : Raises $62.5m to Fund Late Stage Tri... | Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments ... | marketscre... |
17.11.2015 | Amylyx gets $1.9M for ALS, Alzheimer’s drug that mediates or... | “The ALS Finding a Cure Foundation is committed to pursuing multiple avenues toward a cure for ALS,”... | medcitynew... |
- | Amylyx gets $1.9M for ALS, Alzheimer’s drug that mediates or... | Cambridge startup Amylyx Pharmaceuticals is developing a new combination drug product that could hel... | medcitynew... |
- | Amylyx Pharma’s IPO lands $190M as ALS drug begins FDA revie... | Amylyx Pharmaceuticals has joined the public markets with a $190 million IPO that will support the c... | medcitynew... |